Copyright Reports & Markets. All rights reserved.

Global Sterile Injectables Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Sterile Injectables Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Sterile Injectables Market Size Growth Rate by Product
      • 1.4.2 Large Molecules
      • 1.4.3 Small Molecules
    • 1.5 Market by End User
      • 1.5.1 Global Sterile Injectables Market Size Growth Rate by End User
      • 1.5.2 Cancer
      • 1.5.3 Diabetes
      • 1.5.4 Cardiovascular Diseases
      • 1.5.5 Central Nervous Systems
      • 1.5.6 Infectious Disorders
      • 1.5.7 Musculoskeletal
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Sterile Injectables Market Size
      • 2.1.1 Global Sterile Injectables Revenue 2014-2025
      • 2.1.2 Global Sterile Injectables Sales 2014-2025
    • 2.2 Sterile Injectables Growth Rate by Regions
      • 2.2.1 Global Sterile Injectables Sales by Regions
      • 2.2.2 Global Sterile Injectables Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Sterile Injectables Sales by Manufacturers
      • 3.1.1 Sterile Injectables Sales by Manufacturers
      • 3.1.2 Sterile Injectables Sales Market Share by Manufacturers
      • 3.1.3 Global Sterile Injectables Market Concentration Ratio (CR5 and HHI)
    • 3.2 Sterile Injectables Revenue by Manufacturers
      • 3.2.1 Sterile Injectables Revenue by Manufacturers (2014-2019)
      • 3.2.2 Sterile Injectables Revenue Share by Manufacturers (2014-2019)
    • 3.3 Sterile Injectables Price by Manufacturers
    • 3.4 Sterile Injectables Manufacturing Base Distribution, Product Types
      • 3.4.1 Sterile Injectables Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Sterile Injectables Product Type
      • 3.4.3 Date of International Manufacturers Enter into Sterile Injectables Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Sterile Injectables Sales by Product
    • 4.2 Global Sterile Injectables Revenue by Product
    • 4.3 Sterile Injectables Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Sterile Injectables Breakdown Data by End User

    6 North America

    • 6.1 North America Sterile Injectables by Countries
      • 6.1.1 North America Sterile Injectables Sales by Countries
      • 6.1.2 North America Sterile Injectables Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Sterile Injectables by Product
    • 6.3 North America Sterile Injectables by End User

    7 Europe

    • 7.1 Europe Sterile Injectables by Countries
      • 7.1.1 Europe Sterile Injectables Sales by Countries
      • 7.1.2 Europe Sterile Injectables Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Sterile Injectables by Product
    • 7.3 Europe Sterile Injectables by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Sterile Injectables by Countries
      • 8.1.1 Asia Pacific Sterile Injectables Sales by Countries
      • 8.1.2 Asia Pacific Sterile Injectables Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Sterile Injectables by Product
    • 8.3 Asia Pacific Sterile Injectables by End User

    9 Central & South America

    • 9.1 Central & South America Sterile Injectables by Countries
      • 9.1.1 Central & South America Sterile Injectables Sales by Countries
      • 9.1.2 Central & South America Sterile Injectables Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Sterile Injectables by Product
    • 9.3 Central & South America Sterile Injectables by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Sterile Injectables by Countries
      • 10.1.1 Middle East and Africa Sterile Injectables Sales by Countries
      • 10.1.2 Middle East and Africa Sterile Injectables Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Sterile Injectables by Product
    • 10.3 Middle East and Africa Sterile Injectables by End User

    11 Company Profiles

    • 11.1 Baxter International Inc
      • 11.1.1 Baxter International Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Baxter International Inc Sterile Injectables Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Baxter International Inc Sterile Injectables Products Offered
      • 11.1.5 Baxter International Inc Recent Development
    • 11.2 AstraZeneca plc
      • 11.2.1 AstraZeneca plc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 AstraZeneca plc Sterile Injectables Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 AstraZeneca plc Sterile Injectables Products Offered
      • 11.2.5 AstraZeneca plc Recent Development
    • 11.3 Merck & Co., Inc
      • 11.3.1 Merck & Co., Inc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merck & Co., Inc Sterile Injectables Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merck & Co., Inc Sterile Injectables Products Offered
      • 11.3.5 Merck & Co., Inc Recent Development
    • 11.4 Novartis AG
      • 11.4.1 Novartis AG Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Novartis AG Sterile Injectables Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Novartis AG Sterile Injectables Products Offered
      • 11.4.5 Novartis AG Recent Development
    • 11.5 Johnson & Johnson Services, Inc
      • 11.5.1 Johnson & Johnson Services, Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Johnson & Johnson Services, Inc Sterile Injectables Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Johnson & Johnson Services, Inc Sterile Injectables Products Offered
      • 11.5.5 Johnson & Johnson Services, Inc Recent Development

    12 Future Forecast

    • 12.1 Sterile Injectables Market Forecast by Regions
      • 12.1.1 Global Sterile Injectables Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Sterile Injectables Revenue Forecast by Regions 2019-2025
    • 12.2 Sterile Injectables Market Forecast by Product
      • 12.2.1 Global Sterile Injectables Sales Forecast by Product 2019-2025
      • 12.2.2 Global Sterile Injectables Revenue Forecast by Product 2019-2025
    • 12.3 Sterile Injectables Market Forecast by End User
    • 12.4 North America Sterile Injectables Forecast
    • 12.5 Europe Sterile Injectables Forecast
    • 12.6 Asia Pacific Sterile Injectables Forecast
    • 12.7 Central & South America Sterile Injectables Forecast
    • 12.8 Middle East and Africa Sterile Injectables Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Sterile Injectables Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The development and manufacturing of sterile injectables is highly complex and capital intensive.
      The operative cost for injectable is high as almost all injectables in present pharma market are toxic and infectious in natural, consequently, requiring a higher level of quality and significant care needs to be taken in order to ensure safe manufacture, packaging, storage, and distribution.
      Increasing use of biologics in healthcare industry, with the gaining prominence, the emergence of antibody-drug conjugates (ADCs) and monoclonal antibodies (MA) into the drug development and clinical pipeline, has spurred growth of the sterile injectable market worldwide.
      The global Sterile Injectables market is valued at 340 million US$ in 2018 and will reach 580 million US$ by the end of 2025, growing at a CAGR of 6.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sterile Injectables market based on company, product type, end user and key regions.

      This report studies the global market size of Sterile Injectables in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sterile Injectables in these regions.
      This research report categorizes the global Sterile Injectables market by top players/brands, region, type and end user. This report also studies the global Sterile Injectables market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Baxter International Inc
      AstraZeneca plc
      Merck & Co., Inc
      Novartis AG
      Johnson & Johnson Services, Inc

      Market size by Product
      Large Molecules
      Small Molecules
      Market size by End User
      Cancer
      Diabetes
      Cardiovascular Diseases
      Central Nervous Systems
      Infectious Disorders
      Musculoskeletal

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Sterile Injectables market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Sterile Injectables market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Sterile Injectables companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Sterile Injectables submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Sterile Injectables are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sterile Injectables market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now